8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-5.69%
Revenue decline while 3088.T shows 5.25% growth. Joel Greenblatt would examine competitive position erosion.
-5.36%
Cost reduction while 3088.T shows 4.46% growth. Joel Greenblatt would examine competitive advantage.
-7.03%
Gross profit decline while 3088.T shows 7.35% growth. Joel Greenblatt would examine competitive position.
-1.43%
Margin decline while 3088.T shows 2.00% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.46%
Similar other expenses growth to 3088.T's 22.75%. Walter Schloss would investigate industry patterns.
1.09%
Operating expenses growth less than half of 3088.T's 5.24%. David Dodd would verify sustainability.
-4.38%
Total costs reduction while 3088.T shows 4.59% growth. Joel Greenblatt would examine advantage.
-12.12%
Both companies reducing interest expense. Martin Whitman would check industry trends.
10.12%
D&A growth above 1.5x 3088.T's 3.59%. Michael Burry would check for excessive investment.
-21.69%
EBITDA decline while 3088.T shows 9.75% growth. Joel Greenblatt would examine position.
-16.97%
EBITDA margin decline while 3088.T shows 4.28% growth. Joel Greenblatt would examine position.
-30.94%
Operating income decline while 3088.T shows 9.94% growth. Joel Greenblatt would examine position.
-26.77%
Operating margin decline while 3088.T shows 4.46% growth. Joel Greenblatt would examine position.
238.05%
Other expenses growth above 1.5x 3088.T's 21.18%. Michael Burry would check for concerning trends.
-15.31%
Pre-tax income decline while 3088.T shows 1045.28% growth. Joel Greenblatt would examine position.
-10.21%
Pre-tax margin decline while 3088.T shows 988.15% growth. Joel Greenblatt would examine position.
-14.76%
Tax expense reduction while 3088.T shows 98.12% growth. Joel Greenblatt would examine advantage.
-15.78%
Net income decline while 3088.T shows 554.10% growth. Joel Greenblatt would examine position.
-10.70%
Net margin decline while 3088.T shows 531.44% growth. Joel Greenblatt would examine position.
-15.82%
EPS decline while 3088.T shows 2082.54% growth. Joel Greenblatt would examine position.
-15.82%
Diluted EPS decline while 3088.T shows 2082.54% growth. Joel Greenblatt would examine position.
-0.00%
Share count reduction while 3088.T shows 0.00% change. Joel Greenblatt would examine strategy.
-0.00%
Diluted share reduction while 3088.T shows 0.00% change. Joel Greenblatt would examine strategy.